What is Cortechs.ai?
Cortechs.ai operates at the intersection of artificial intelligence and medical imaging, providing clinicians with high-precision tools to detect and monitor complex neurological and oncological conditions. The company's platform integrates seamlessly into existing clinical workflows, offering automated image analysis, disease quantification, and lesion tracking. By delivering quantitative insights, Cortechs.ai empowers radiologists, neurologists, and oncologists to make more informed diagnostic decisions, ultimately driving the adoption of precision medicine in modern healthcare environments.
How much funding has Cortechs.ai raised?
Cortechs.ai has raised a total of $3.6M across 3 funding rounds:
Series A
$2M
Series B
$1.2M
Debt
$350K
Series A (2013): $2M, investors not publicly disclosed
Series B (2014): $1.2M, investors not publicly disclosed
Debt (2020): $350K supported by PPP
Key Investors in Cortechs.ai
PPP
Public-Private Partnership
Undisclosed Investor
A strategic partner providing capital to support the company's early-stage growth and technological development.
Undisclosed Investor
A financial backer involved in the company's Series B expansion phase, focusing on scaling AI-driven medical imaging solutions.
What's next for Cortechs.ai?
With this recent infusion of capital, Cortechs.ai is well-positioned to accelerate its product roadmap and expand its footprint in the global medical imaging market. The strategic focus will likely shift toward enhancing the interoperability of its AI-driven tools within hospital information systems and deepening its clinical validation studies. As the company matures, it aims to further refine its diagnostic decision support capabilities, ensuring that its technology remains at the forefront of radiology intelligence and patient-centric care delivery.
See full Cortechs.ai company page
